EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A homozygous EVC mutation in a prenatal fetus with Ellis–van Creveld syndrome

Jie Wang, Xiaohua Wang, Yueqi Jia, Xiangnan Li, Guohui Liu iD, Rula Sa, Haiquan Yu iD

Molecular Genetics & Genomic Medicine · 2023

DOI: 10.1002/mgg3.2183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2023. Verfasst von Jie Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock (RRBGL), Inner Mongolia University, Hohhot, 010070, China. Hauptthemen laut MEDLINE: Membrane Proteins, Ellis-Van Creveld Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ellis–van Creveld (EvC) syndrome, caused by variants in EVC , is a rare genetic skeletal dysplasia. Its clinical phenotype is highly diverse. EvC syndrome is rarely reported in prenatal stages because its presentation overlaps with other diseases.

Methods

A Chinese pedigree diagnosed with EvC syndrome was enrolled in this study. Whole‐exome sequencing (WES) was applied in the proband to screen potential genetic variant(s), and then Sanger sequencing was used to identify the variant in family members. Minigene experiments were applied.

Results

WES identified a homozygous variant (NM_153717.3:c.153_174 + 42del) in EVC which was inherited from the heterozygous parents and confirmed by Sanger sequencing. Further experiments demonstrated that this variant disrupts the canonical splicing site and produces a new splicing site at NM_153717.3: c.‐164_174del, which ultimately leads to a 337 bp deletion at the 3′ end of exon 1 and loss of the start codon.

Conclusion

This is the first reported case of EvC syndrome based on a splicing variant and detailed delineation of the aberrant splicing effect in the fetus. Our study demonstrates the pathogenesis of this new variant, expands the spectrum of EVC mutations, and demonstrates that WES is a powerful tool in the clinical diagnosis of diseases with genetic heterogeneity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsEllis-Van Creveld SyndromeHumansIntercellular Signaling Peptides and ProteinsMutationFetus

Stichwörter der Autor:innen

EVCEllis-van Creveld syndromeaberrant splicing effectskeletal dysplasia

Substanzen

Membrane ProteinsIntercellular Signaling Peptides and ProteinsEVC protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock (RRBGL), Inner Mongolia University, Hohhot, 010070, China.
  • Department of Genetics, Inner Mongolia Maternity and Child Health Care Hospital, Hohhot, 010010, China.
  • Department of Ultrasonic Medicine, Inner Mongolia Maternity and Child Health Care Hospital, Hohhot, 010010, China.

ORCID-Profile: Guohui Liu, Haiquan Yu

Zitieren

APA

Wang, J., Wang, X., Jia, Y., Li, X., Liu, G., Sa, R., & Yu, H. (2023). A homozygous EVC mutation in a prenatal fetus with Ellis–van Creveld syndrome. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2183

Vancouver

Wang J, Wang X, Jia Y, Li X, Liu G, Sa R, et al. A homozygous EVC mutation in a prenatal fetus with Ellis–van Creveld syndrome. Molecular Genetics & Genomic Medicine. 2023. doi:10.1002/mgg3.2183

BibTeX
@article{Wang2023,
  author = {Wang, Jie and Wang, Xiaohua and Jia, Yueqi and Li, Xiangnan and Liu, Guohui and Sa, Rula and Yu, Haiquan},
  title = {A homozygous EVC mutation in a prenatal fetus with Ellis–van Creveld syndrome},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2023},
  doi = {10.1002/mgg3.2183}
}
Kostenlos starten →